Cargando…

Monoclonal Antibodies to Intracellular Stages of Cryptosporidium parvum Define Life Cycle Progression In Vitro

Among the obstacles hindering Cryptosporidium research is the lack of an in vitro culture system that supports complete life development and propagation. This major barrier has led to a shortage of widely available anti-Cryptosporidium antibodies and a lack of markers for staging developmental progr...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilke, Georgia, Ravindran, Soumya, Funkhouser-Jones, Lisa, Barks, Jennifer, Wang, Qiuling, VanDussen, Kelli L., Stappenbeck, Thaddeus S., Kuhlenschmidt, Theresa B., Kuhlenschmidt, Mark S., Sibley, L. David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5976880/
https://www.ncbi.nlm.nih.gov/pubmed/29848759
http://dx.doi.org/10.1128/mSphere.00124-18
_version_ 1783327254113157120
author Wilke, Georgia
Ravindran, Soumya
Funkhouser-Jones, Lisa
Barks, Jennifer
Wang, Qiuling
VanDussen, Kelli L.
Stappenbeck, Thaddeus S.
Kuhlenschmidt, Theresa B.
Kuhlenschmidt, Mark S.
Sibley, L. David
author_facet Wilke, Georgia
Ravindran, Soumya
Funkhouser-Jones, Lisa
Barks, Jennifer
Wang, Qiuling
VanDussen, Kelli L.
Stappenbeck, Thaddeus S.
Kuhlenschmidt, Theresa B.
Kuhlenschmidt, Mark S.
Sibley, L. David
author_sort Wilke, Georgia
collection PubMed
description Among the obstacles hindering Cryptosporidium research is the lack of an in vitro culture system that supports complete life development and propagation. This major barrier has led to a shortage of widely available anti-Cryptosporidium antibodies and a lack of markers for staging developmental progression. Previously developed antibodies against Cryptosporidium were raised against extracellular stages or recombinant proteins, leading to antibodies with limited reactivity across the parasite life cycle. Here we sought to create antibodies that recognize novel epitopes that could be used to define intracellular development. We identified a mouse epithelial cell line that supported C. parvum growth, enabling immunization of mice with infected cells to create a bank of monoclonal antibodies (MAbs) against intracellular parasite stages while avoiding the development of host-specific antibodies. From this bank, we identified 12 antibodies with a range of reactivities across the parasite life cycle. Importantly, we identified specific MAbs that can distinguish different life cycle stages, such as trophozoites, merozoites, type I versus II meronts, and macrogamonts. These MAbs provide valuable tools for the Cryptosporidium research community and will facilitate future investigation into parasite biology. IMPORTANCE Cryptosporidium is a protozoan parasite that causes gastrointestinal disease in humans and animals. Currently, there is a limited array of antibodies available against the parasite, which hinders imaging studies and makes it difficult to visualize the parasite life cycle in different culture systems. In order to alleviate this reagent gap, we created a library of novel antibodies against the intracellular life cycle stages of Cryptosporidium. We identified antibodies that recognize specific life cycle stages in distinctive ways, enabling unambiguous description of the parasite life cycle. These MAbs will aid future investigation into Cryptosporidium biology and help illuminate growth differences between various culture platforms.
format Online
Article
Text
id pubmed-5976880
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher American Society for Microbiology
record_format MEDLINE/PubMed
spelling pubmed-59768802018-05-31 Monoclonal Antibodies to Intracellular Stages of Cryptosporidium parvum Define Life Cycle Progression In Vitro Wilke, Georgia Ravindran, Soumya Funkhouser-Jones, Lisa Barks, Jennifer Wang, Qiuling VanDussen, Kelli L. Stappenbeck, Thaddeus S. Kuhlenschmidt, Theresa B. Kuhlenschmidt, Mark S. Sibley, L. David mSphere Research Article Among the obstacles hindering Cryptosporidium research is the lack of an in vitro culture system that supports complete life development and propagation. This major barrier has led to a shortage of widely available anti-Cryptosporidium antibodies and a lack of markers for staging developmental progression. Previously developed antibodies against Cryptosporidium were raised against extracellular stages or recombinant proteins, leading to antibodies with limited reactivity across the parasite life cycle. Here we sought to create antibodies that recognize novel epitopes that could be used to define intracellular development. We identified a mouse epithelial cell line that supported C. parvum growth, enabling immunization of mice with infected cells to create a bank of monoclonal antibodies (MAbs) against intracellular parasite stages while avoiding the development of host-specific antibodies. From this bank, we identified 12 antibodies with a range of reactivities across the parasite life cycle. Importantly, we identified specific MAbs that can distinguish different life cycle stages, such as trophozoites, merozoites, type I versus II meronts, and macrogamonts. These MAbs provide valuable tools for the Cryptosporidium research community and will facilitate future investigation into parasite biology. IMPORTANCE Cryptosporidium is a protozoan parasite that causes gastrointestinal disease in humans and animals. Currently, there is a limited array of antibodies available against the parasite, which hinders imaging studies and makes it difficult to visualize the parasite life cycle in different culture systems. In order to alleviate this reagent gap, we created a library of novel antibodies against the intracellular life cycle stages of Cryptosporidium. We identified antibodies that recognize specific life cycle stages in distinctive ways, enabling unambiguous description of the parasite life cycle. These MAbs will aid future investigation into Cryptosporidium biology and help illuminate growth differences between various culture platforms. American Society for Microbiology 2018-05-30 /pmc/articles/PMC5976880/ /pubmed/29848759 http://dx.doi.org/10.1128/mSphere.00124-18 Text en Copyright © 2018 Wilke et al. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research Article
Wilke, Georgia
Ravindran, Soumya
Funkhouser-Jones, Lisa
Barks, Jennifer
Wang, Qiuling
VanDussen, Kelli L.
Stappenbeck, Thaddeus S.
Kuhlenschmidt, Theresa B.
Kuhlenschmidt, Mark S.
Sibley, L. David
Monoclonal Antibodies to Intracellular Stages of Cryptosporidium parvum Define Life Cycle Progression In Vitro
title Monoclonal Antibodies to Intracellular Stages of Cryptosporidium parvum Define Life Cycle Progression In Vitro
title_full Monoclonal Antibodies to Intracellular Stages of Cryptosporidium parvum Define Life Cycle Progression In Vitro
title_fullStr Monoclonal Antibodies to Intracellular Stages of Cryptosporidium parvum Define Life Cycle Progression In Vitro
title_full_unstemmed Monoclonal Antibodies to Intracellular Stages of Cryptosporidium parvum Define Life Cycle Progression In Vitro
title_short Monoclonal Antibodies to Intracellular Stages of Cryptosporidium parvum Define Life Cycle Progression In Vitro
title_sort monoclonal antibodies to intracellular stages of cryptosporidium parvum define life cycle progression in vitro
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5976880/
https://www.ncbi.nlm.nih.gov/pubmed/29848759
http://dx.doi.org/10.1128/mSphere.00124-18
work_keys_str_mv AT wilkegeorgia monoclonalantibodiestointracellularstagesofcryptosporidiumparvumdefinelifecycleprogressioninvitro
AT ravindransoumya monoclonalantibodiestointracellularstagesofcryptosporidiumparvumdefinelifecycleprogressioninvitro
AT funkhouserjoneslisa monoclonalantibodiestointracellularstagesofcryptosporidiumparvumdefinelifecycleprogressioninvitro
AT barksjennifer monoclonalantibodiestointracellularstagesofcryptosporidiumparvumdefinelifecycleprogressioninvitro
AT wangqiuling monoclonalantibodiestointracellularstagesofcryptosporidiumparvumdefinelifecycleprogressioninvitro
AT vandussenkellil monoclonalantibodiestointracellularstagesofcryptosporidiumparvumdefinelifecycleprogressioninvitro
AT stappenbeckthaddeuss monoclonalantibodiestointracellularstagesofcryptosporidiumparvumdefinelifecycleprogressioninvitro
AT kuhlenschmidttheresab monoclonalantibodiestointracellularstagesofcryptosporidiumparvumdefinelifecycleprogressioninvitro
AT kuhlenschmidtmarks monoclonalantibodiestointracellularstagesofcryptosporidiumparvumdefinelifecycleprogressioninvitro
AT sibleyldavid monoclonalantibodiestointracellularstagesofcryptosporidiumparvumdefinelifecycleprogressioninvitro